CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Drugs.com New Drug Approvals
Original article

FDA Approves Rasonque (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

FDA Decision

Read the original article

Published by Drugs.com New Drug Approvals on August 26, 2026 11:08 PM

Read Original